News & Reports

News and Reports

Select year

2022 2021 2020 2019 2018 Earlier
shown/page
15
5 10 15 20

2017.03.27

Dr. Lu Xianping was invited to attend 2017 Asia Pacific Drug Research and Development Leader Summit
Dr. Lu Xianping was invited to attend 2017 Asia Pacific Drug Research and Development Leader Summit

Full text

2017.03.13

Chidamide won the most clinically valuable innovative medicine of the second China Pharmaceutical Innovative Brand in 2016
Chidamide won the most clinically valuable innovative medicine of the second China Pharmaceutical Innovative Brand in 2016

Full text

2017.01.05

Our company has won the national titles of " high-tech enterprise" and " Shenzhen high-tech enterprise"
Our company has won the national titles of " high-tech enterprise" and " Shenzhen high-tech enterprise"

Full text

2016.12.27

As a representative of Pingshan's innovation drive, our company was reported by Guangming net and other media
As a representative of Pingshan's innovation drive, our company was reported by Guangming net and other media

Full text

2016.11.29

Phase III clinical trial of Chiglitazar, a new CHIPSCREEN BIOSCIENCES anti-type 2 diabetes drug, completed
Phase III clinical trial of Chiglitazar, a new CHIPSCREEN BIOSCIENCES anti-type 2 diabetes drug, completed

Full text

2016.11.29

The second HDACi ( histone deacetylase inhibitor ) summit was successfully held in Chengdu
The second HDACi ( histone deacetylase inhibitor ) summit was successfully held in Chengdu

Full text

2016.11.09

CHIPSCREEN BIOSCIENCES was invited to attend 2016 Huaxing Capital healthcare and life science and technology leader summit
CHIPSCREEN BIOSCIENCES was invited to attend 2016 Huaxing Capital healthcare and life science and technology leader summit

Full text

2016.11.09

CHIPSCREEN BIOSCIENCES was invited to DIA China's second drug research innovation conference
CHIPSCREEN BIOSCIENCES was invited to DIA China's second drug research innovation conference

Full text

2016.11.09

CHIPSCREEN BIOSCIENCES was invited to attend the first China oncology clinical trial summit
CHIPSCREEN BIOSCIENCES was invited to attend the first China oncology clinical trial summit

Full text

2016.10.09

CHIPSCREEN BIOSCIENCES was invited to attend international lymphoma special conference of 2016 CSC0 academic conference
CHIPSCREEN BIOSCIENCES was invited to attend international lymphoma special conference of 2016 CSC0 academic conference

Full text

2016.10.09

CHIPSCREEN BIOSCIENCES was invited to attend the fifth China rare disease summit forum in 2016
CHIPSCREEN BIOSCIENCES was invited to attend the fifth China rare disease summit forum in 2016

Full text

2016.10.09

CHIPSCREEN BIOSCIENCES was invited to participate in 2016 international clinical and translational medicine forum
CHIPSCREEN BIOSCIENCES was invited to participate in 2016 international clinical and translational medicine forum

Full text

2016.09.22

Dr. Lu Xianping from CHIPSCREEN BIOSCIENCES was invited to give lectures at the " lecture hall for 1,000 people" of China Pharmaceutical University.
Dr. Lu Xianping from CHIPSCREEN BIOSCIENCES was invited to give lectures at the " lecture hall for 1,000 people" of China Pharmaceutical University.

Full text

2016.09.22

Dr. Lu Xianping was invited to attend the 20th session of the lecture on understanding the future - challenging the forefront of science: life science and artificial intelligence
Dr. Lu Xianping was invited to attend the 20th session of the lecture on understanding the future - challenging the forefront of science: life science and artificial intelligence

Full text

2016.08.16

Dr. Lu Xianping was invited to attend the 2016 International Forum on Immunization and Disease Research and the 70th Anniversary of Jilin University in Changchun
Dr. Lu Xianping was invited to attend the 2016 International Forum on Immunization and Disease Research and the 70th Anniversary of Jilin University in Changchun

Full text
Media contact

Media contact

  • Media contact

    (+86)0755-36993500

  • Media contact

    pr@chipscreen.com